Hypoxic Ischemic Encephalopathy of Newborn
10
4
5
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
10.0%
1 terminated out of 10 trials
0.0%
-86.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (10)
Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)
Investigating Cerebral Oxygenation in the Newborn
The HIEnome Study: Genome Sequencing for Perinatal HIE
Feasibility and Safety of Intranasally Administered Breast Milk in HIE
Chest Physical Therapy on Arterial Blood Gases for Neonates Post Hypoxic Ischemic Encephalopathy
Continuous Glucose Monitoring in HIE
Role of Citicoline in Treatment of Neonates With Hypoxic Ischemic Encephalopathy
Continuous Versus Bolus Feeding in Neonates With Hypoxic Ischemic Encephalopathy
Metformin Treatment in Infants After Perinatal Brain Injury
Maternal and Neonatal Risk Factors of HIE